Subject: Smallcap Discoveries: IBEX Technologies (IBT-TSX.V) Interview with CEO Paul Baehr

Smallcap Discoveries:
IBEX Technologies (IBT-TSX.V) Interview with CEO Paul Baehr
On February 11th, we had an interview with CEO Paul Baehr of IBEX Technologies and below is a short summary on the company and our video interview.

ABOUT IBEX

IBEX manufactures and markets proteins for biomedical use through its wholly-owned subsidiary IBEX Pharmaceuticals Inc. (Montréal, QC). IBEX Pharmaceuticals also manufactures and markets a series of arthritis assays, which are widely used in osteoarthritis research.

Video Interview:
After our interviews, we host a session with the live participants to provide our thoughts on the Company as well as commentary on companies from both the Select Portfolio and Select Watchlist.

86 East 23rd Ave, v5v 1w9, Vancouver, Canada
You may unsubscribe or change your contact details at any time.

Powered by:
GetResponse

    This is an online snapshot of a newsletter created by the owner of Small Cap Premium Service (DJ Dunkerley, 86 East 23rd Ave, v5v 1w9 Vancouver, Canada) and sent via GetResponse on 2021-02-12. Report abuse